How to find the best strategy for you ?
Value
Our factor investing score meticulously assesses the intrinsic value of each asset, providing invaluable insights into its potential for long-term growth.
Growth
With a keen focus on growth prospects, our factor investing score analyzes each asset's trajectory, offering strategic guidance for maximizing returns in dynamic market conditions..
Quality
With an emphasis on quality metrics, our factor investing score meticulously evaluates the fundamental strength and stability of each asset, safeguarding your portfolio against potential risks.
Volatility
By meticulously evaluating volatility, our factor investing score helps you navigate market turbulence, ensuring a balanced portfolio resilient to unpredictable fluctuations.
Momentum
Leveraging momentum analysis, our factor investing score identifies assets poised for upward trends, empowering you to capitalize on market momentum for optimized performance.
Yield
Focused on yield optimization, our factor investing score identifies assets with attractive income potential, enabling you to construct a diversified portfolio tailored to your income objectives.
Create a reliable strategy with the A-Score
Undervalued company with stable and reliable business like Warren Buffet
Get detailled Investment Case for more than 5500 Stocks
Strong Company Updates
Get a complete corporate access : reliable, clear, and always available at the time you need it
Delta(DAL): None
None
Apr -08
RPM International(RPM): None
None
Apr -08
Acuity Brands(AYI): Acuity Brands Q2 2026: Solid Sales, Margin Gains, and AI‑Driven Upside
Net sales rose 5% to $1.10 billion, with AIS driving growth and ABL offsetting a 3% decline. Adjusted operating profit climbed 12%, and diluted EPS hit $4.14, beating estimates of $4.01. Gross margin at 45.7% up 70 bp reflects strategic pricing and productivity gains. Valuation sits at a P/E of 20.12 and a P/B of 3.04, underscoring the market’s confidence in continued margin discipline.
Apr -02
Quality Equity Research. Easy Access
Get started with our cost-effective equity research
Monthly
Annual Up to 30% Discount
Free Trial
FREE
7 Days- Unlimited access to Watchlist
- Unlimited access to screener
- Unlimited access to AI Assistant
- Access to US Investment Case
- API calls limited to 10/day
- Request new coverage
- Premium Support
Premium
$39.99
per month
- Unlimited access to Watchlist
- Unlimited access to screener
- Unlimited access to AI Assistant
- Unlimited access to Investment Case
- API calls limited to 250/day
- Request new coverage
- Premium Support
Ultimate
$99.90
- Unlimited access to Watchlist
- Unlimited access to screener
- Unlimited access to AI Assistant
- Unlimited access to Investment Case
- API calls limited to 2500/minute
- Request new coverage
- Premium Support
